News
Learn more about how C3i takes part in the development of new cell and gene therapies.
-
Nov 13, 2017C3i is attending the NeoAntigen Summit in Boston!
Read MoreC3i will attend the Neoantigen Summit in Boston from November 14th to 16th to hear about the latest developments in neoantigen discovery and monitoring.
-
Nov 13, 2017C3i’s Biomarker and Diagnostic unit now offers TCR-beta sequencing services
Read MoreThe Center for Commercialization of Cancer Immunotherapy (C3i) is proud to announce the availability of T cell receptor-beta sequencing services in its Biomarker and Diagnostic unit.
-
Sep 30, 2017C3i participates to the challenge Cycle for a Cure!
Read MoreThe 6th edition of the Bike Challenge for Cellular Therapy Research at the Maisonneuve-Rosemont Hospital will give you the opportunity to support scientific work that promotes healing.